Gold Standard Diagnostics Europe is pleased to announce the launch of GSD NovaType Detect + Select SARS-CoV-2. This assay has been designed to detect SARS-CoV-2 genomic RNA and to identify Spike (S) mutations R346K and Y449H, as well as ORF1a mutation I3731V.
Assay main features:
- Identification of SARS-CoV-2 N gene (targets: N1/N2) and S gene mutations in one reaction.
- An optional Primer-Probe-Mix allows additional detection of the S gene mutation Y449H (only compatible with certain RT-PCR cyclers).
- Specimen types: nasal lavage/swab, nasopharyngeal swab, oropharyngeal swab
- Validated PCR platforms: AriaMxTM, AriaDxTM (Agilent Technologies)
Please contact us if you are interested in further information. We are looking forward to hearing back from you.
All new SARS-CoV-2 tests can be ordered online at our Webshop.